TABLE 1.
Drug | Measurement | Value (mean ±SEM) |
|||
---|---|---|---|---|---|
7G8a |
D10b |
||||
L263 | 263E | L263 | 263E | ||
Artemisinin | Absolute IC50 (nM) | 20.7 ± 2.9 | 22.3 ± 1.7 | 42.8 ± 5.0 | 51.6 ± 5.5 |
Normalized IC50 | 1.00 ± 0.11 | 1.30 ± 0.12 | 1.00 ± 0.12 | 1.20 ± 0.13 | |
No. of assays | 12 | 28 | 11 | 21 | |
Dihydroartemisinin | Absolute IC50 (nM) | 2.26 ± 0.29 | 2.37 ± 0.18 | 3.41 ± 0.36 | 3.96 ± 0.35 |
Normalized IC50 | 1.00 ± 0.10 | 1.33 ± 0.13 | 1.00 ± 0.11 | 1.18 ± 0.10 | |
No. of assays | 12 | 28 | 13 | 27 | |
Artesunate | Absolute IC50 (nM) | 13.5 ± 1.7 | 14.9 ± 1.4 | 23.6 ± 3.1 | 26.2 ± 2.8 |
Normalized IC50 | 1.00 ± 0.09 | 0.97 ± 0.07 | 1.00 ± 0.09 | 0.99 ± 0.08 | |
No. of assays | 12 | 28 | 13 | 27 |
7G8 L263 refers to C17G8 and C27G8; 7G8 263E refers to M17G8, M27G8, M37G8, and M47G8.
D10 L263 refers to C1D10 and C2D10; D10 263E refers to M1D10, M2D10, and M3D10.